相关实验视频

Updated: Jun 4, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

量化PD-L1表达和瘤突变负担在生物学上不同的晚期胰腺癌中,这些癌症对 pembrolizumab 有反应:病例报告

Kevin Y Li1,2, Andrew M Lowy1,2, Paul Fanta2,3

  • 1Department of Surgery, Division of Surgical Oncology, University of California, San Diego, San Diego, CA, United States.

Frontiers in immunology
|December 17, 2024
PubMed
概括

检查点封锁对抗常规治疗的晚期胰腺癌有希望. 评估生物标志物,如综合阳性评分和瘤突变负担,可以指导有效的免疫疗法策略.

关键词:
在CPS中,使用CPS是非常重要的.TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB免疫疗法 免疫疗法胰腺腺癌的癌症.胰腺的神经内分泌瘤

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.5K

相关概念视频